$1.73
0.1610.19%
Last update: Nov 6, 7:59 PM
Nkarta Inc (NKTX) Stock Price, Quote, News & History
NKTXNASDAQ
Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.
You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.
Other companies in Nkarta’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Nkarta has a consensus price target of $12.86.
The stock price for Nkarta (NASDAQ: NKTX) is $1.8699 last updated November 6, 2026 at 7:59 PM EST.
There are no upcoming dividends for Nkarta.
Nkarta does not have any upcoming earnings scheduled.
There is no upcoming split for Nkarta.
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and...
